We’re proud to share that Dr. Jun Ding’s pioneering AI4Health research has been spotlighted by Anaconda, the world’s most widely used AI platform with over 40 million users.
Jun Ding leads a team developing advanced AI models to accelerate drug discovery for diseases like Idiopathic Pulmonary Fibrosis (IPF). Their work, supported by Anaconda’s platform, identified a safe and affordable hypertension drug, costing about $10 per month, that could perform as well as current IPF therapies priced at $10,000 per month.
Beyond drug discovery, his team also created the AI tool scSemiProfiler that cuts the cost of single-cell sequencing projects by up to 90%, making large-scale studies that were once financially out of reach possible.
Recognition by Anaconda underscores the visibility and global impact of Jun Ding’s AI4Health research, reinforcing his leadership at the intersection of artificial intelligence and medicine.
Read the Case Study on Anaconda.com
McGill Researchers Discover $10 Drug Candidate to Replace $10,000 Treatment. How AI scientists leveraged the Anaconda AI Platform to identify a $10 drug that could replace a $10,000 treatment and save countless lives. Anaconda.com, October 2025.